SCHOLL ADVANCE ATHLETES FOOT

Method of administration Cutaneous use Adults and the Elderly Scholl Advance Athlete’s Foot Cream is applied once or twice daily to the affected skin and surrounding area in a thin layer and rubbed in gently. Before application the affected skin areas should be cleansed and dried thoroughly.

In the case of intertriginous infections (interdigital) the application may be covered with a gauze strip, especially at night. Duration of treatment is one week for tinea pedis. Relief of symptoms usually occurs within a few days. Irregular use or premature discontinuation of treatment carries the risk of recurrence.

If there are no signs of improvement after two weeks, the diagnosis should be verified by a physician. Children Scholl Advance Athlete’s Foot Cream is not recommended for use in children below 16 years due to insufficient data on safety and efficacy.

2.

Adverse events which have been associated with terbinafine hydrochloride are given below, tabulated by system organ class and frequency. Frequencies are defined as very common ≥1/10; common ≥1/100 <1/10; uncommon ≥1/1000 <1/100; rare ≥1/10,000 <1/1000; very rare ≤1/10,000.

Not known (cannot be estimated from the available data). Within each frequency grouping, adverse events are presented in order of decreasing seriousness. System Organ Class Frequency Adverse Events Immune System Disorders Rare Hypersensitivity1, 2 Uncommon Pruritus, erythemaSkin and Subcutaneous Tissue Disorders Not known Skin burning sensation Uncommon StingingGeneral Disorders and Administration Site Conditions Not known Application site irritation2 Description of selected Adverse Reactions 1 Hypersensitivity reactions include rash or urticaria.

2 Treatment has to be rarely discontinued for allergic reactions at the site of application. However if hypersensitivity reactions occur treatment must be discontinued. Reporting of Suspected Adverse Reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.

It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

This product is for external use only. Contact with the eyes, face and mucous membranes should be avoided. g. contact dermatitis). Contact with skin lesions should be avoided. This medicine contains 10mg benzyl alcohol in 1g-cream. Benzyl alcohol may cause allergic reactions and mild local irritation.

Discontinue use if irritation occurs.

Hypersensitivity to terbinafine or any of the excipients in the cream.